Drug Patents owned by Sarfe Pharms

1. List of Soaanz drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10154963 SARFE PHARMS Controlled-release formulations comprising Torsemide
Oct, 2033

(10 years from now)

Do you want to check out SOAANZ patents from before 2022?

Drugs and Companies using TORSEMIDE ingredient

Market Authorisation Date: 14 June, 2021

Treatment: NA


More Information on Dosage

SOAANZ family patents


United States


European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in